Induction of apoptosis by chemotherapeutic drugs: The role of FADD in activation of caspase-8 and synergy with death receptor ligands in ovarian carcinoma cells

被引：0

作者：

Milner A.E. ^{[1
]}

Palmer D.H. ^{[1
]}

Hodgkin E.A. ^{[1
]}

Eliopoulos A.G. ^{[1
]}

Knox P.G. ^{[1
]}

Poole C.J. ^{[1
]}

Kerr D.J. ^{[1
]}

Young L.S. ^{[1
]}

机构：

[1] CRC Institute for Cancer Studies, Clinical Research Block, University of Birmingham

来源：

Cell Death & Differentiation | 2002年 / 9卷 / 3期

基金：

英国医学研究理事会;

关键词：

Adenovirus; Apoptosis; Death receptors; Drug resistance; Ovarian carcinoma;

D O I：

10.1038/sj.cdd.4400945

中图分类号：

学科分类号：

摘要：

Although ovarian tumours initially respond to chemotherapy, they gradually acquire drug resistance. The aims of this study were to identify how chemotherapeutic drugs with diverse cellular targets activate apoptotic pathways and to investigate the mechanism by which exposure to a combination of drugs plus death receptor ligands can increase tumour cell kill. The results show that drugs with distinct cellular targets differentially up-regulate TRAIL and TNF as well CD95L, but do not require interaction of these ligands with their receptor partners to induce cell death. Factors that were critical in drug-induced apoptosis were activation of caspases, with caspase-8 being activated by diverse drugs in a FADD-independent manner. Certain drugs also demonstrated some dependence on FADD in the induction of cell death. Caspase-9 was activated more selectively by chemotherapeutic agents. Combining ligation of death receptors with exposure to drugs increased tumour cell kill in both drug resistant cell lines and primary ovarian carcinoma cells, even though these cells were not sensitive to death receptor ligation alone. CD95L was more consistent at combining with drugs than TRAIL or TNF. Investigation of the mechanism by which a combination of drugs plus CD95 ligation can increase cell death showed that caspase-8 was activated in cells exposed to a combination of cisplatin and anti-CD95, but not in cells exposed to either agent alone.

引用

页码：287 / 300

页数：13

共 44 条

[11]

Ruiz-Ruiz M., Lopez-Rivas A., p53-mediated upregulation of CD95 is not involved in genotoxic drug-induced apoptosis of human breast tumour cells, Cell Death Differ., 6, pp. 271-280, (1999)

[12]

Micheau O., Solary E., Hammann A., Dimanche-Boitrel M.-T., Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs, J. Biol. Chem., 274, pp. 7987-7992, (1999)

[13]

Katoaka T., Schroter M., Hahne M., Schneider P., Irmler M., Thome M., Froelich C., Tschopp J., FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs and gamma irradiation, J. Immunol., 161, pp. 3936-3942, (1998)

[14]

Cock J.G., deVries E., Williams G.T., Borst J., The anti-cancer drug etoposide can induce caspase-8 processing and apoptosis in the absence of CD95 receptor-ligand interaction, Apoptosis, 3, pp. 17-25, (1998)

[15]

Landowsi T.H., Shain K.H., Oshiro M.M., Buyuksai I., Painter J.S., Dalton W.S., Myeloma cells selected for resistance to CD95-mediated apoptosis are not cross-resistant to cytotoxic drugs, Blood, 94, pp. 265-274, (1999)

[16]

Henkels K.M., Turchi J.J., Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and cisplatin-sensitive human ovarian cancer cell lines, Cancer Res., 59, pp. 3077-3083, (1999)

[17]

Ueta E., Yoneda K., Yamamoto T., Osaki T., Manganese superoxide dismutase negatively regulates the induction of apoptosis by 5-fluorouracil, peplomycin and gamma-rays in squamous carcinoma cells, Japanese J. Cancer Res., 90, pp. 555-564, (1999)

[18]

Scrivastava R.K., Mi Q.S., Hardwick J.M., Longo D.L., Deletion of the loop region of Bcl-2 completely blocks paclitaxel-induced apoptosis, Proc. Natl. Acad. Sci., 96, pp. 3775-3780, (1999)

[19]

Eliopoulos A.G., Kerr D.J., Herod J., Hodgkins L., Krajewski S., Reed J.C., Young L.S., The control of apoptosis and drug resistance in ovarian cancer: Influence of p53 and Bcl-2, Oncogene, 11, pp. 1217-1228, (1995)

[20]

Siemer S., Ornskov D., Guerra B., Boldyreff B., Issinger O.G., Determination of mRNA and protein levels of p53, MDM2 and protein kinase CK2 subunits in F9 cells after treatment with the apoptosis-inducing drugs cisplatin and carboplatin, Int. J. Biochem. and Cell Biol., 31, pp. 661-670, (1999)

← 1 2 3 4 5 →